BamSEC and AlphaSense Join Forces
Learn More

Terns Pharmaceuticals Inc. – Material Contracts

Formerly NASDAQ: TERN
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.6(F)
from 10-K 2 pages Amendment No. 3 to 2022 Employment Inducement Award Plan of Terns Pharmaceuticals, Inc. * * *
12/34/56
EX-10.11
from 10-K 13 pages Terns, Inc
12/34/56
EX-10.7
from 10-K 4 pages Terns Pharmaceuticals, Inc. Second Amended and Restated Non-Employee Director Compensation Program
12/34/56
EX-10.2
from 10-Q 16 pages Terns, Inc. February 21, 2025
12/34/56
EX-10.1
from 10-Q 13 pages Terns Pharmaceuticals, Inc. Consulting Agreement This Consulting Agreement (This “Agreement”) Is Made and Entered Into as of February 1, 2025 (The “Effective Date”) by and Between Terns Pharmaceuticals, Inc. (The “Company”), and Mark Vignola (“Consultant”) (Each Herein Referred to Individually as a “Party,” or Collectively as the “Parties”). Whereas, the Company Desires to Retain Consultant as an Independent Contractor to Perform Consulting Services for the Company, and Consultant Is Willing to Perform Such Services, on the Terms Described Below; And
12/34/56
EX-10.9
from 10-K 5 pages Terns Pharmaceuticals, Inc. Second Amended and Restated Non-Employee Director Compensation Program
12/34/56
EX-10.3
from 10-Q 2 pages Amendment No. 2 to 2022 Employment Inducement Award Plan of Terns Pharmaceuticals, Inc. * * *
12/34/56
EX-10.2
from 10-Q 11 pages July 23, 2024 Personal and Confidential by Email Mark Vignola Dear Mark
12/34/56
EX-10.1
from 10-Q 10 pages July 23, 2024 Personal and Confidential by Email
12/34/56
EX-10.1
from 10-Q 11 pages May 7, 2024 Personal and Confidential by Email Erin Quirk Dear Erin
12/34/56
EX-10.1
from 8-K 7 pages First Amendment to Office Lease
12/34/56
EX-10.2
from 10-Q 17 pages Terns, Inc. February 6, 2024
12/34/56
EX-10.1
from 10-Q 5 pages Terns Pharmaceuticals, Inc. Second Amended and Restated Non-Employee Director Compensation Program
12/34/56
EX-10.10
from 10-K 15 pages Terns, Inc. November 14, 2023
12/34/56
EX-10.9
from 10-K 3 pages Terns, Inc. November 14, 2023
12/34/56
EX-10.8
from 10-K 15 pages Terns, Inc. November 14, 2023
12/34/56
EX-10.6
from 10-K 15 pages Terns, Inc. November 14, 2023
12/34/56
EX-10.3
from 10-Q 4 pages Terns Pharmaceuticals, Inc. Compensation Recovery Policy
12/34/56
EX-10.2
from 10-Q 2 pages Amendment No. 1 to 2022 Employment Inducement Award Plan of Terns Pharmaceuticals, Inc. * * *
12/34/56
EX-10.1
from 10-Q 14 pages August 2, 2023 Personal and Confidential by Email
12/34/56